KNSA
Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares
$46.36
2.08%
+0.95
Notify me if price changes either direction
Buy KNSA stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
3.6B
Enterprise value
3.1B
Trailing PE
59.53247
Forward PE
28.261406
PEG Ratio
-0.23044827096774
Enterprise to EBITDA
39.411
Enterprise to revenue
4.582
Price to book MRQ
6.16129
Price to sales TTM
5.1779337
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2025-12-31
Revenue (TTM)
677.6M
EBITDA
78.8M
Diluted EPS TTM
0.77
Total Cash (MRQ)
414.1M
Current ratio (MRQ)
3.788
Operating Cash Flow (TTM)
138.0M
KNSA trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
March 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
